EN HU

Tóthfalusi Dávid

Tóthfalusi Dávid

Publication list

2026
1.
Jóna, Á., Tóthfalusi, D., Illés, Á., Miltényi, Z.: Bispecific Antibodies in B-Cell Lymphomas: mechanisms, Efficacy, Toxicity, and Management.
Medicina (Kaunas). 62 (2), 1-17, (article identifier: 342), 2026.
Journal metrics:
Q2 Medicine (miscellaneous) (2025)
2025
2.
Miltényi, Z., Dobó, B., Tóthfalusi, D., Pinczés, L. I.: Beszámoló a 13. Nemzetközi Hodgkin lymphoma Szimpóziumról (ISHL).
Hematol. Trasnzfuziol. 58 (1), 45, 2025.
3.
Pinczés, L. I., Tóthfalusi, D., Dobó, B., Barna, S., Farkas, B., Garai, I., Illés, Á., Miltényi, Z.: [delta]SUVmax adds prognostic value to early response assessment during the first-line treatment of classical Hodgkin lymphoma: a retrospective cohort study.
Cancer Imaging. 25 (1), 1-8, (article identifier: 80), 2025.
Journal metrics:
Q1 Medicine (miscellaneous)
Q2 Oncology
Q1 Radiological and Ultrasound Technology
Q1 Radiology, Nuclear Medicine and Imaging
4.
Tóthfalusi, D., Gulyás, A., Koncz, A., Zöld, É., Illés, Á., Miltényi, Z.: Hodgkin Lymphoma Associated with Common Variable Immunodeficiency: the Role of Early Diagnosis and Multidisciplinary Management.
Hematol Rep. 17 (6), 1-15, (article identifier: 65), 2025.
Journal metrics:
Q3 Hematology
5.
Tóthfalusi, D., Dobó, B., Borics, F., Pinczés, L. I., Illés, Á., Miltényi, Z.: Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma.
Clinics and Practice. 15 (1), 1-16, (article identifier: 15), 2025.
Journal metrics:
Q2 Medicine (miscellaneous)
2024
6.
Illés, Á., Dobó, B., Borics, F., Tóthfalusi, D., Pinczés, L. I., Miltényi, Z.: The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin's Lymphoma Patients (1980-2019).
Medicina (Kaunas). 60 (8), 1-15, (article identifier: 1272), 2024.
Journal metrics:
Q2 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen